Rigel Pharmaceuticals, Inc. (RIGL)
39.65
-6.06
(-13.26%)
USD |
NASDAQ |
Nov 06, 16:00
39.60
-0.05
(-0.13%)
After-Hours: 20:00
Rigel Pharmaceuticals Max Drawdown (5Y) : 86.40% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 86.40% |
| September 30, 2026 | 86.40% |
| August 31, 2026 | 86.40% |
| July 31, 2026 | 86.40% |
| June 30, 2026 | 86.40% |
| May 31, 2026 | 86.40% |
| April 30, 2026 | 86.40% |
| March 31, 2026 | 86.40% |
| February 28, 2026 | 86.40% |
| January 31, 2026 | 86.40% |
| December 31, 2025 | 86.40% |
| November 30, 2025 | 86.40% |
| October 31, 2025 | 86.40% |
| September 30, 2025 | 86.40% |
| August 31, 2025 | 86.40% |
| July 31, 2025 | 86.40% |
| June 30, 2025 | 86.40% |
| May 31, 2025 | 86.40% |
| April 30, 2025 | 86.40% |
| March 31, 2025 | 86.40% |
| February 28, 2025 | 86.40% |
| January 31, 2025 | 86.40% |
| December 31, 2024 | 86.40% |
| November 30, 2024 | 86.40% |
| October 31, 2024 | 86.40% |
| Date | Value |
|---|---|
| September 30, 2024 | 86.40% |
| August 31, 2024 | 86.40% |
| July 31, 2024 | 86.40% |
| June 30, 2024 | 86.40% |
| May 31, 2024 | 86.40% |
| April 30, 2024 | 86.40% |
| March 31, 2024 | 86.40% |
| February 29, 2024 | 86.40% |
| January 31, 2024 | 86.40% |
| December 31, 2023 | 86.40% |
| November 30, 2023 | 86.40% |
| October 31, 2023 | 86.40% |
| September 30, 2023 | 86.40% |
| August 31, 2023 | 86.40% |
| July 31, 2023 | 86.40% |
| June 30, 2023 | 86.40% |
| May 31, 2023 | 86.40% |
| April 30, 2023 | 86.40% |
| March 31, 2023 | 86.40% |
| February 28, 2023 | 86.40% |
| January 31, 2023 | 86.40% |
| December 31, 2022 | 86.40% |
| November 30, 2022 | 86.40% |
| October 31, 2022 | 86.35% |
| September 30, 2022 | 86.35% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Cytokinetics, Inc. | 72.39% |
| Inovio Pharmaceuticals, Inc. | 99.62% |
| United Therapeutics Corp. | 33.00% |
| Verastem, Inc. | 97.04% |
| Marker Therapeutics, Inc. | 99.42% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -5.513 |
| Beta (5Y) | 1.278 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 96.57% |
| Historical Sharpe Ratio (5Y) | 0.0516 |
| Historical Sortino (5Y) | 0.1288 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.02% |